160 related articles for article (PubMed ID: 35409289)
1. MicroRNA 3928 Suppresses Glioblastoma through Downregulation of Several Oncogenes and Upregulation of p53.
Mulcahy EQX; Zhang Y; Colόn RR; Cain SR; Gibert MK; Dube CJ; Hafner M; Abounader R
Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409289
[TBL] [Abstract][Full Text] [Related]
2. miR-3174 Is a New Tumor Suppressor MicroRNA That Inhibits Several Tumor-Promoting Genes in Glioblastoma.
Hanif F; Zhang Y; Dube C; Gibert MK; Saha S; Hudson K; Marcinkiewicz P; Kefas B; Guessous F; Abounader R
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298284
[TBL] [Abstract][Full Text] [Related]
3. p53 and miR-210 regulated NeuroD2, a neuronal basic helix-loop-helix transcription factor, is downregulated in glioblastoma patients and functions as a tumor suppressor under hypoxic microenvironment.
Agrawal R; Garg A; Benny Malgulwar P; Sharma V; Sarkar C; Kulshreshtha R
Int J Cancer; 2018 May; 142(9):1817-1828. PubMed ID: 29226333
[TBL] [Abstract][Full Text] [Related]
4. PDGF-B-mediated downregulation of miR-21: new insights into PDGF signaling in glioblastoma.
Costa PM; Cardoso AL; Pereira de Almeida LF; Bruce JN; Canoll P; Pedroso de Lima MC
Hum Mol Genet; 2012 Dec; 21(23):5118-30. PubMed ID: 22922228
[TBL] [Abstract][Full Text] [Related]
5. MiR-449a exerts tumor-suppressive functions in human glioblastoma by targeting Myc-associated zinc-finger protein.
Yao Y; Ma J; Xue Y; Wang P; Li Z; Li Z; Hu Y; Shang X; Liu Y
Mol Oncol; 2015 Mar; 9(3):640-56. PubMed ID: 25487955
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-128-3p Enhances the Chemosensitivity of Temozolomide in Glioblastoma by Targeting c-Met and EMT.
Zhao C; Guo R; Guan F; Ma S; Li M; Wu J; Liu X; Li H; Yang B
Sci Rep; 2020 Jun; 10(1):9471. PubMed ID: 32528036
[TBL] [Abstract][Full Text] [Related]
7. Mir-370-3p Impairs Glioblastoma Stem-Like Cell Malignancy Regulating a Complex Interplay between HMGA2/HIF1A and the Oncogenic Long Non-Coding RNA (lncRNA) NEAT1.
Lulli V; Buccarelli M; Ilari R; Castellani G; De Dominicis C; Di Giamberardino A; D Alessandris QG; Giannetti S; Martini M; Stumpo V; Boe A; De Luca G; Biffoni M; Marziali G; Pallini R; Ricci-Vitiani L
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32443824
[TBL] [Abstract][Full Text] [Related]
8. Mir-660 is downregulated in lung cancer patients and its replacement inhibits lung tumorigenesis by targeting MDM2-p53 interaction.
Fortunato O; Boeri M; Moro M; Verri C; Mensah M; Conte D; Caleca L; Roz L; Pastorino U; Sozzi G
Cell Death Dis; 2014 Dec; 5(12):e1564. PubMed ID: 25501825
[TBL] [Abstract][Full Text] [Related]
9. miR-135b suppresses tumorigenesis in glioblastoma stem-like cells impairing proliferation, migration and self-renewal.
Lulli V; Buccarelli M; Martini M; Signore M; Biffoni M; Giannetti S; Morgante L; Marziali G; Ilari R; Pagliuca A; Larocca LM; De Maria R; Pallini R; Ricci-Vitiani L
Oncotarget; 2015 Nov; 6(35):37241-56. PubMed ID: 26437223
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-340 inhibits prostate cancer cell proliferation and metastasis by targeting the MDM2-p53 pathway.
Huang K; Tang Y; He L; Dai Y
Oncol Rep; 2016 Feb; 35(2):887-95. PubMed ID: 26718483
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-575 acts as a novel oncogene via targeting multiple signaling pathways in glioblastoma.
Gray A; Cui T; Bell EH; McElroy J; Sebastian E; Li F; Geurts M; Liu K; Robe P; Haque SJ; Chakravarti A
Exp Mol Pathol; 2022 Oct; 128():104813. PubMed ID: 35901926
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-21 promotes glioblastoma tumorigenesis by down-regulating insulin-like growth factor-binding protein-3 (IGFBP3).
Yang CH; Yue J; Pfeffer SR; Fan M; Paulus E; Hosni-Ahmed A; Sims M; Qayyum S; Davidoff AM; Handorf CR; Pfeffer LM
J Biol Chem; 2014 Sep; 289(36):25079-87. PubMed ID: 25059666
[TBL] [Abstract][Full Text] [Related]
13. The miR-92b functions as a potential oncogene by targeting on Smad3 in glioblastomas.
Wu ZB; Cai L; Lin SJ; Lu JL; Yao Y; Zhou LF
Brain Res; 2013 Sep; 1529():16-25. PubMed ID: 23892108
[TBL] [Abstract][Full Text] [Related]
14. Human glioblastoma multiforme: p53 reactivation by a novel MDM2 inhibitor.
Costa B; Bendinelli S; Gabelloni P; Da Pozzo E; Daniele S; Scatena F; Vanacore R; Campiglia P; Bertamino A; Gomez-Monterrey I; Sorriento D; Del Giudice C; Iaccarino G; Novellino E; Martini C
PLoS One; 2013; 8(8):e72281. PubMed ID: 23977270
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-503 acts as a tumor suppressor in glioblastoma for multiple antitumor effects by targeting IGF-1R.
Zhang Y; Chen X; Lian H; Liu J; Zhou B; Han S; Peng B; Yin J; Liu W; He X
Oncol Rep; 2014 Mar; 31(3):1445-52. PubMed ID: 24378652
[TBL] [Abstract][Full Text] [Related]
16. The role of miR-18b in MDM2-p53 pathway signaling and melanoma progression.
Dar AA; Majid S; Rittsteuer C; de Semir D; Bezrookove V; Tong S; Nosrati M; Sagebiel R; Miller JR; Kashani-Sabet M
J Natl Cancer Inst; 2013 Mar; 105(6):433-42. PubMed ID: 23365201
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of microRNA-129-5p in glioblastoma inhibits cell proliferation, migration, and colony-forming ability by targeting ZFP36L1.
Guo X; Piao H; Zhang Y; Sun P; Yao B
Bosn J Basic Med Sci; 2020 Nov; 20(4):459-470. PubMed ID: 31999936
[TBL] [Abstract][Full Text] [Related]
18. LncRNA miR143HG inhibits the proliferation of glioblastoma cells by sponging miR-504.
Wang P; Bao W; Liu X; Xi W
Int J Neurosci; 2022 Nov; 132(11):1137-1142. PubMed ID: 33461388
[TBL] [Abstract][Full Text] [Related]
19. RUNX1 (RUNX family transcription factor 1), a target of microRNA miR-128-3p, promotes temozolomide resistance in glioblastoma multiform by upregulating multidrug resistance-associated protein 1 (MRP1).
Xu J; Song J; Xiao M; Wang C; Zhang Q; Yuan X; Tian S
Bioengineered; 2021 Dec; 12(2):11768-11781. PubMed ID: 34895074
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of miR-21 inhibits EGFR pathway and suppresses the growth of human glioblastoma cells independent of PTEN status.
Zhou X; Ren Y; Moore L; Mei M; You Y; Xu P; Wang B; Wang G; Jia Z; Pu P; Zhang W; Kang C
Lab Invest; 2010 Feb; 90(2):144-55. PubMed ID: 20048743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
